Heme A is a prosthetic group confined exclusively to mitochondrial and some bacterial cytochrome oxidases. Heme A differs from heme B (protoheme) at the porphyrin carbons C-2, where a vinyl group is replaced by a farnesyl group, and at C-8, where there is a formyl instead of a methyl substituent (1). The first step in heme A biosynthesis is a farnesylation of the vinyl at C-2 of heme B (2). In Saccharomyces cerevisiae this reaction, resulting in heme O, is catalyzed by a mitochondrial farnesyl transferase encoded by COX10 1 (3, 4). Heme O itself is a prosthetic group in some bacterial cytochrome oxidases (5). The further conversion of heme O to heme A probably involves a monooxygenase-catalyzed hydroxylation of the methyl group at C-8. The resultant alcohol would then be further oxidized to the aldehyde.
Heme A is a prosthetic group confined exclusively to mitochondrial and some bacterial cytochrome oxidases. Heme A differs from heme B (protoheme) at the porphyrin carbons C-2, where a vinyl group is replaced by a farnesyl group, and at C-8, where there is a formyl instead of a methyl substituent (1) . The first step in heme A biosynthesis is a farnesylation of the vinyl at C-2 of heme B (2) . In Saccharomyces cerevisiae this reaction, resulting in heme O, is catalyzed by a mitochondrial farnesyl transferase encoded by COX10 1 (3, 4) . Heme O itself is a prosthetic group in some bacterial cytochrome oxidases (5) . The further conversion of heme O to heme A probably involves a monooxygenase-catalyzed hydroxylation of the methyl group at C-8. The resultant alcohol would then be further oxidized to the aldehyde.
In a screen of cytochrome oxidase-deficient yeast strains for lesions in heme A biosynthesis, only cox15 mutants were found to have heme O but not heme A. This observation led us to propose that Cox15p catalyzes the hydroxylation of the C-8 methyl group (6) . According to this mechanism, oxidation of the methyl to the alcohol is catalyzed by a three-component monooxygenase that includes Cox15p, mitochondrial ferredoxin, and ferredoxin reductase, encoded by YAH1 and ARH1, respectively (7, 8) .
In the present study we have further assessed the role of ferredoxin in heme A synthesis. Temperature-sensitive yah1 mutants have been used to measure heme A synthesis over a range of temperatures that elicit the increasing loss of ferredoxin activity. The ts mutants have also been used to measure the incorporation of ␦-aminolevulinic acid into heme A following the shift to the non-permissive temperature. Finally, we have examined the effect of overexpression of ferredoxin and Cox15p singly or in combination on the heme composition of various yeast mutants. The results of these studies strongly support the involvement of ferredoxin and by inference of ferredoxin reductase in heme A synthesis.
MATERIALS AND METHODS
Yeast Strains and Media-The genotypes and sources of the strains of S. cerevisiae used in this study are listed in Table I . The following media were used to grow yeast YPD (2% glucose, 2% peptone, 1% yeast extract), YEPG (3% glycerol, 2% ethanol, 2% peptone, 1% yeast extract), and YPGal (2% galactose, 2% peptone, 1% yeast extract). Solid media contained 2% agar.
Extraction and Separation of Mitochondrial Hemes-Mitochondria prepared as described previously (13) were suspended in 0.5 M sorbitol, 20 mM Tris-HCl (pH 7.5), and 0.5 mM EDTA at a protein concentration of 20 mg/ml. Total heme was extracted from 2 mg of mitochondrial protein with 0.5 ml of acetone containing 2.5% HCl. The mixture was vortexed, clarified by centrifugation, and mixed with an equal volume of 50% acetonitrile. Insoluble material was removed by a second centrifugation. The extract was adjusted to approximately pH 3.5 with 1.65 M ammonium hydroxide, clarified by centrifugation, and applied to a 3.9 ϫ 300 mm C18 Bondclone column (Phenomenex, Torrance, CA). Hemes were eluted at a flow rate of 1 ml/min using a 30 -50% acetonitrile gradient over the first 5 ml, followed by a 50 -75% linear acetonitrile gradient over the subsequent 35 ml. The acetonitrile solutions contained 0.05% trifluoroacetic acid. The elution of heme compounds was monitored at 400 nm. Fluorescent porphyrin compounds were monitored at an excitation wavelength of 400 nm and an emission wavelength of 600 nm. The elution times are affected by the pH of the sample applied to the column. The elution time of heme B was determined with a commercial preparation. The heme A standard was extracted from partially purified cytochrome oxidase, and heme O from Escherichia coli.
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ʈ To whom correspondence should be addressed. Tel.: 212-854-2920; Fax: 212-865-8246; E-mail: spud@cubpet2.bio.columbia.edu. 1 The abbreviations used are: COX, cytochrome oxidase; HPLC, high pressure liquid chromatography. (14) to obtain YIp351-GAL and YIplac204-GAL, respectively. COX15 was amplified with the primers 5Ј-GGCCGGATCCATATAAATGCTTT-TCAGAAACATAG and 5Ј-GGCAAGCTTATATGGTTTCGAGG using pG4/T1 (10) as a template. The 1.475-kb product was digested with BamHI and HindIII and ligated to YIp351-GAL and YIplac204-GAL, yielding plasmids pGCOX15-1 and pGCOX15-3, respectively. The onestep gene insertion method (15) was used to integrate the gene at the LEU2 or TRP1 locus of yeast chromosomal DNA.
Preparation of Antibodies to Cox15p-Antibodies were obtained against Cox15p expressed from a trpE fusion gene. The 648-bp PstISacI fragment containing the region of COX15 coding for 216 carboxylterminal residues of Cox15p was fused in-frame to the amino-terminal half of trpE in pATH21 (16) . E. coli transformed with this plasmid expresses a fusion protein of about 53 kDa, constituting most of the insoluble proteins of the cells. This fraction was dissolved in a 10 mM Tris-HCl, 1mM EDTA (pH 7.5) buffer containing 2% SDS, 5 mM ␤-mercaptoethanol, and 20 g/ml phenylmethylsulfonyl fluoride and was further purified on a Bio-Gel A 0.5 column developed with a buffer containing 10 mM Tris-HCl, 0.1mM EDTA, and 5 mM ␤-mercaptoethanol. Fractions enriched for the fusion protein were pooled, concentrated by acetone precipitation, and used to raise antibodies in rabbits.
YAH1 Temperature-sensitive Mutants-YAH1 temperature-sensitive mutants were obtained by PCR amplification of the wild type gene in pYAH/ST1 (7) under mutagenic conditions. The primers used for the synthesis were 5Ј-CCTATTTTTTCTCTGCAGCAATGC and 5Ј-AATCTT-TCAAAGCTTGTAGCAGTT. Synthesis of the gene was carried out in four separate reactions containing 0.25 mM MnCl 2 , 1.5 mM MgCl 2 , and 0.2 mM dITP. In each reaction the concentration of one of the four deoxynucleotides was reduced from 0.2 to 0.02 mM. To construct the mutant library, the four 950-bp products were pooled and cloned in the centromeric plasmid YCp22 containing the TRP1 marker (14) . This library was used to transform the diploid heterozygous mutant strain a/␣W303⌬YAH1. Tryptophan-independent transformants obtained after several days of incubation of the selective plates at 30°C were pooled and spread on potassium acetate sporulation medium. After 3 days, meiotic progeny issued from the diploid transformants were selected at 30°C for both uracil (gene disruption marker) and tryptophan (plasmid marker) prototrophy. The Trp ϩ and Ura ϩ colonies were replicated on two YPD plates and incubated overnight at 30°C and 37°C. Two mutants (W303⌬YAH1/CR4, W303⌬YAH1/CR4) displaying lethality at 37°C were purified, and their plasmids (pYAH1/CR4, pYAH1/CR5) were used to back-transform the original diploid mutant strain. The plasmid dependence of the ts phenotype in the second generation transformants was confirmed by segregation and tetrad analysis. The sequences of the yah1 genes in pYAH1/CR4 and pYAH1/CR5 were each found to have six different base substitutions leading to amino acid changes in ferredoxin. The protein encoded by pYAH1/CR4 had the following mutations: L39F, S71C, P122L, I146T, K150E, and P160L. The last three mutations were at conserved residues. The mutations in the protein encoded by pYAH1/CR5 were S15P, P57L, E59D, P120Q, G135W, and S172R. Only one mutation (G135W) was at a conserved residue.
COX15 Temperature-sensitive Mutants-Previously identified cox15 mutants (47 independent strains) (9) were screened for temperaturesensitive revertants. Each strain was grown in YPD, and 10 7 cells were plated on YEPG. Spontaneous revertants were collected after up to 1 week of incubation of the YEPG plates at 30°C. The revertants were purified and tested for temperature-sensitive growth on YEPG. From the 47 original mutants, 8 produced revertants of which 2 (C126/R and P147/R) exhibited slower growth at 37°C.
Miscellaneous Procedures-Standard procedures were used for the preparation and ligation of DNA fragments and for transformation and recovery of plasmid DNA from E. coli (17) . Yeast was transformed by the method of Schiestl and Gietz (18) . Total mitochondrial proteins were separated by polyacrylamide gel electrophoresis in the buffer system of Laemmli (19) , and Western blots were treated with antibodies against the appropriate proteins followed by a second reaction with anti-mouse or anti-rabbit IgG conjugated to horseradish peroxidase (Sigma). Cox15p was detected on Western blots with the antibody against the trpE fusion protein (see above), and Yah1p and Cox15p-Yah1p were detected with an antibody against a short synthetic peptide with a Yah1p sequence (7) . The antibody-antigen complexes were visualized by the SuperSignal chemiluminescent substrate kit (Pierce). The accumulation of heme O in some cytochrome oxidase mutants made it possible to look at the effect of increased Cox15p, ferredoxin, or a combination of the two on in vivo conversion of this intermediate to heme A. To overexpress Cox15p, mutants were transformed with an integrative plasmid containing COX15 under the control of the GAL10 promoter (GAL10-COX15 fusion). YAH1 coding for mitochondrial ferredoxin was introduced on a high copy episomal plasmid. To ensure retention of the YAH1-bearing plasmid, all the strains transformed with this gene had a null yah1 allele in addition to the mutations in the cytochrome oxidase specific genes. The extent of the increase of Cox15p and ferredoxin in the mitochondria of strains transformed with these plasmids was estimated to be at least 20-fold (Fig. 1) . Mitochondrial hemes of cells grown in YPGal were quantitated by HPLC. The results comparing the effect of Cox15p and ferredoxin alone or of the two together on the concentrations of heme A and heme O in a cox11 mutant background are shown in Fig. 2 . The function of Cox11p in yeast is likely to be the same as in Rhodobacter where the homologous protein has been shown to be required for biogenesis of the CuB center in subunit 1 (20) . The values for heme A are normalized to heme B, the concentration of which in different mutants is relatively constant. These results show that integration of the GAL10-COX15 fusion into the chromosomal DNA of the mutant elicits a 20-fold increase in heme A (Fig. 2C) . The heme A content was increased by another factor of four in cells overexpressing both Cox15p and ferredoxin (Fig. 2D) . No increase of heme A was observed in mutant cells transformed with the high copy YAH1 plasmid (Fig. 2B) . The ratio of heme O to heme B in these strains changed inversely to the heme A/heme B ratio.
RESULTS

Heme A Accumulation in Cytochrome Oxidase
Two other cytochrome oxidase mutants, sco1 and imp2, were also transformed with the COX15 and YAH1 plasmids, and their mitochondrial hemes were assayed. SCO1 is involved in mitochondrial copper metabolism (10, 21) , and IMP2 codes for a subunit of the intermembrane protease that processes mitochondrial proteins, including the precursor form of subunit 2 of cytochrome oxidase (22) . The introduction of the GAL10-COX15 fusion alone increased the heme A concentration in these mutants as it did in the cox11 mutant, and when combined with the YAH1 the effect was even more pronounced (Fig.  3) . This was especially evident in the imp2 mutant where overexpression of both proteins raised the heme A content to half of that seen in wild type yeast. Although the increase in heme A in the imp2 mutant was accompanied by a decrease in heme O, this was not true of the sco1 mutant in which both
FIG. 1. Overexpression of Cox15p and ferredoxin in yeast transformed with a chromosomally integrated GAL10-COX15
fusion gene and with YAH1 in a multicopy plasmid. Mitochondria were prepared from the wild type (W303), the cox11-null mutant (⌬COX11), the cox11 mutant with an integrated copy of the GAL10-COX15 fusion (⌬COX11/iCOX15), and from the cox11,yah1 double mutant with YAH1 on a multicopy plasmid (⌬COX11⌬YAH1/ST1). Total mitochondrial proteins (40 g) were separated by SDS-PAGE on a 12 or 15% polyacrylamide gel, transferred to nitrocellulose, and probed with antibodies against Cox15p and ferredoxin. The migration of molecular mass standards is indicated in the margin. The arrows point to the positions of Cox15p and ferredoxin. Cox15p migrates with an apparent size of 43 kDa or ϳ12 kDa less than predicted from the amino acid sequence. A similar discrepancy was also seen in the Cox15-bio fusion protein reported earlier (10) . The difference in the size of the primary translation product and of the mature protein as estimated by SDS-PAGE electrophoresis suggests the presence of a very long aminoterminal targeting sequence.
FIG. 2. Effect of overexpression of Cox15p and/or ferredoxin
on the mitochondrial concentration of heme A and heme O in a cox11 mutant. The mutant and transformant strains were grown in YPGal medium. Hemes were extracted from isolated mitochondria with acidified acetone and separated by reverse phase chromatography on a C18 column (see "Materials and Methods"). A, the cox11-null mutant (⌬COX11). B, the cox11,yah1 double mutant harboring YAH1 on a high copy plasmid (⌬COX11⌬YAH1/ST1). C, the cox11-null mutant with the integrated GAL10-COX15 fusion (⌬COX11/iCOX15). D, the cox11,yah1 double mutant with the integrated GAL10-COX15 fusion and YAH1 on a high copy plasmid (⌬COX11⌬YAH1/ST1-iCOX15). The peaks corresponding to heme B, heme A, and heme O are indicated. The ratios of heme A/heme B (A/B) and heme O/heme B (O/B) were calculated from the areas under the peaks.
heme O and heme A were increased when the mutant was transformed with the two genes (data not shown).
Growth Properties of Temperature-sensitive Mutants-To facilitate further experiments on the role of ferredoxin in heme A synthesis, temperature-sensitive yah1 mutants were obtained by low stringency PCR amplification of the gene. The doubling times in the rich glucose medium of the wild type W303-1A and two yah1 ts mutants, W303⌬YAH1/CR4 and W303⌬YAH1/ CR5, were determined before and after the shift from 30°C to 37°C. Both mutants and the wild type had generation times of ϳ2 h at 30°C in this medium. The growth of W303⌬YAH1/CR5 was arrested completely 1.5 h after the shift to 37°C (Fig. 4A) . Although the generation time of W303⌬YAH1/CR4 was also affected at the restrictive temperature, the effect was not as pronounced. Growth of this mutant was six times slower 1.5 h after the shift to 37°C. As expected, the wild type strain grew about two times slower at 37°C. Similar growth kinetics were observed in rich YPGal.
Growth of the cox15 revertant P146/R in liquid YEPG confirmed visual observations of its partial temperature sensitivity on solid medium. Although P146/R grew almost as well as the wild type at 30°C, its growth was 3-4 times slower compared with the wild type at 37°C (Fig. 4B) 
Effect of Growth Temperature on Heme A Synthesis in Wild Type and in Temperature-sensitive cox15 and yah1 Mutants-
The requirement of Cox15p and ferredoxin for heme A synthesis was examined by measuring the concentrations of heme A relative to heme B in the mitochondria of cells grown at different temperatures. Even though the doubling times of W303⌬YAH1/CR4 and W303⌬YAH1/CR5 are considerably longer at higher temperatures, enough cells can be obtained even at 34°C for mitochondrial heme analyses.
The wild type and the three ts mutants were grown at 27°C, 32.5°C, and 34°C in a rich galactose medium. Mitochondria were prepared and their hemes separated by HLPC. The ratios of the heme A to heme B were determined for each strain grown at the three different temperatures. The results of these analyses, summarized in Fig. 5 , indicate that whereas the ratio of heme A to heme B in the wild type is constant over the temperature range examined, it decreases progressively as a function of increasing temperature in the mutants. It is noteworthy that the more severe the temperature sensitivity the lower the ratio at all temperatures measured, indicating partial loss of activity even at the permissive temperature. The lowest ratio was observed in W303⌬YAH1/CR5, the more stringent of the two yah1 mutants. The cox15 mutant, the growth of which is least affected at the restrictive temperature, also shows the least decrease in the ratio of heme A to heme B.
Incorporation of ␦-Aminolevulinic Acid into Heme A and Heme B in yah1 ts Mutants-␦-Aminolevulinic acid is a specific precursor of heme (23) . The incorporation of this precursor into heme A was compared at 30 and 37°C in the wild type and the yah1 mutants W303⌬YAH1/R4 and W303⌬YAH1/R5. Cells FIG. 5 . Heme A/heme B ratios in yah1 and cox15 ts mutants grown at different temperatures. The wild type W303-1A (W303), the cox15 ts mutant (P146/R), and the two yah1 ts mutants W303⌬YAH1/CR4 (CR4) and W303⌬YAH1/CR5 (CR5) were grown in 2% rich galactose medium to approximately the same cell density at 27, 32.5, and 34°C. Mitochondria were prepared, and their heme A and heme B concentrations were assayed as described in the Fig. 2 legend.   FIG. 3 . Heme A/heme B ratios in different cytochrome oxidase mutants and transformants. Mitochondria were prepared from parental wild type (W303), from the sco1, cox11, and imp2-null mutants (⌬sco1, ⌬cox11, ⌬imp2), from the null mutants harboring a chromosomally integrated copy of the GAL10-COX15 fusion (⌬sco1/iCOX15, ⌬cox11/iCOX15, ⌬imp2/iCOX15), from the double mutants harboring YAH1 on a high copy plasmid (⌬sco1⌬yah1/ST1, ⌬cox11 ⌬yah1/ST1, ⌬imp2 ⌬yah1/ST1), and finally from the double mutants with the chromosomally integrated GAL10-COX15 fusion and YAH1 on a high copy plasmid (⌬sco1⌬yah1/ST1-iCOX15, ⌬cox11 ⌬yah1/ST1-iCOX15, ⌬imp2 ⌬yah1/ST1-iCOX15). Mitochondrial heme A and heme B were measured as described in the Fig. 2 legend. The values shown for the strains with the cox11 mutation were obtained from the HPLC analyses shown in Fig. 2.   FIG. 4. Growth of yah1 and cox15 ts mutants at 30 and 37°C . A, the parental wild type strain W303-1A (W303) and the yah1-null mutant harboring pYAH1/CR4 (CR4) or pYAH1/CR5 (CR5) were grown at 30°C in liquid YPD medium for 3.5 h after which the temperature was raised to 37°C. Growth was monitored by absorbance at 600 nm. The generation times of the three strains at the two temperatures are shown in the inset. The generation time after the temperature shift was measured from the difference in absorbances between 5 and 10 h. B, the wild type strain W303-1A and the cox15 ts revertant P146/R were grown in liquid YEPG at 30°C for 3.5 h after which the temperature was raised to 37°C. The generation times are shown in the inset. The generation time at 37°C was calculated from the difference in absorbances between 6 and 10 h. grown at 30°C were transferred to medium containing radioactive ␦-aminolevulinic and were further incubated at 30 and 37°C. Hemes were extracted from zymolyase-treated cells or mitochondria and separated by reverse phase chromatography, and the radioactivity associated with heme B and heme A was determined. The results of one such experiment, illustrated in Fig. 6 , show the incorporation of the radioactive precursor into heme B and heme A at 30 and 37°C in the wild type and the ts mutant W303⌬YAH1/R5. The ratio of counts in heme A to heme B was not much different at the two temperatures in the wild type, but was reduced at 37°C in the mutant. Despite the poor labeling of heme probably as a result of inefficient uptake of ␦-aminolevulinic in yeast, the results of several experiments indicated a consistent decrease of heme A labeling at 37°C in both yah1 ts mutants but not in the wild type (Table II) . No radioactivity was detected in heme O at either temperature. This is probably due to the failure of mutants blocked in heme A synthesis to accumulate heme O.
DISCUSSION
In mammals, ferredoxin (adrenodoxin) together with ferredoxin reductase and cytochrome P450 have been shown to catalyze hydroxylation of cholesterol to pregnenolone (24) . In contrast to cytochrome P450, which is detected only in the mitochondria of steroidogenic tissues, ferredoxin and ferredoxin reductase are found in the mitochondria of widely divergent sources (25, 26) , suggesting that they may function in other pathways. This suggestion is supported by recent evidence that in yeast, ferredoxin (27, 28) and ferredoxin reductase (29) play a role in the assembly of iron-sulfur clusters. Because iron-sulfur clusters are present not only in mitochondria but in many cytoplasmic proteins, ferredoxin and its reductase are essential for cell viability (7, 8) . In an earlier paper we proposed still another function for ferredoxin in heme A biosynthesis (6) .
The conversion of heme O to heme A is likely to involve an initial hydroxylation of the C-8 methyl. This reaction is probably catalyzed by a three-component monooxygenase consisting of Cox15p, ferredoxin, and ferredoxin reductase (6) . The evidence for Cox15p as a component of the monooxygenase was based on the presence of heme O but not heme A in cox15 mutants (6) . Cox15p also shares weak sequence similarity to the bacterial CtaA protein that had been implicated to have a function in the synthesis of heme A from heme O (30, 31) . The presence of a single fusion gene composed of COX15 and YAH1 in Schizosaccharomyces pombe (GenBank TM accession no. In experiment 1 (Exp. 1) hemes were extracted from zymolyase-treated cells. In all the other experiments hemes were extracted from mitochondria. Cells were converted to spheroplasts by treatment with zymolyase at 37°C for 10 min. The lysis of spheroplasts and the further isolation of mitochondria have been described (13) . The results of Exp. 3 were calculated from the data shown in Fig. 6 and the ts yah1 mutant (⌬YAH1/ CR5) were grown in 800 ml of YPGal to mid-log phase. Cells were harvested, and equal halves were transferred to each of two flasks containing 100 ml of YPGal with one-fifth the normal concentrations of yeast extract and peptone and 150 Ci of ␦-[
3 H]aminolevulinic acid (3 Ci/mmol; PerkinElmer Life Sciences). The cells were incubated at 30 and 37°C for 3 h, mitochondria were prepared, and heme A and heme B concentrations were assayed as in Fig. 2 . Fractions of 1 ml were collected and counted to an accuracy of 5%. The ratio of heme B and heme A estimated from the areas under the peaks and the ratios of counts (corrected for background) in the two hemes are shown in the different panels.
Z70043) further suggested that the two proteins might be functionally related. This was consistent with the notion that the hydroxylation step may be catalyzed by a P450-like monooxygenase deriving electrons from NADPH or NADH through ferredoxin. The present studies were undertaken to obtain more direct evidence for the essentiality of ferredoxin in heme A synthesis.
The synthesis of heme A relative to heme B in temperaturesensitive ferredoxin mutants is reduced as a function of increased temperature. Similarly, incorporation of the heme precursor, ␦-aminolevulinic acid, is substantially less in the yah1 mutants than in the wild type following the shift to the non-permissive temperature. Both observations are consistent with a role of ferredoxin in heme A synthesis. The partial temperaturesensitive cox15 allele also caused a progressive decline in the heme A/heme B ratio in cells grown at increasingly higher temperatures.
Mutations in a large number of genes affecting the expression of cytochrome oxidase produce a general phenotype, the features of which include the absence of cytochromes a and a 3 and greatly reduced steady state levels of the subunits constituting the catalytic core of the enzyme (10 -12, 32) . Such mutants are also severely deficient in heme A but not heme O, which accumulates to different extents depending on the mutant (6) . 2 The increase of heme O in cytochrome oxidase mutants was taken advantage of to determine whether the heme A content could be raised by overexpression of Cox15 and/or ferredoxin. The concentration of heme A was not significantly affected by ferredoxin but in some cases could be increased by as much as 40-fold in mutants transformed with COX15 (Fig.  3) . Heme A was even higher in mutants transformed with both COX15 and YAH1. In addition to supporting the involvement of Cox15p and ferredoxin in heme A synthesis, these data suggest that normally Cox15p is more limiting than ferredoxin or the reductase in the hydroxylation of heme O. In mutants transformed with the GAL10-COX15 fusion gene, however, ferredoxin appears to be more limiting than Cox15p.
Heme A is barely detectable in the imp2 mutant, and its concentration is raised to approximately half that of the wild type in cells overexpressing COX15 and YAH1. Even though the concentration of Cox15p in the mutant is not appreciably different from that in the wild type, it has 45 times more heme O than the wild type (data not shown). The low concentration of heme A, therefore, cannot be a consequence of the lower expression of COX15. The ability of such mutants to accumulate large amounts of heme O, the structure of which is closely related to heme A, also tends to argue against degradation as the cause of the heme A deficit. A more plausible explanation at present is that the pathway is down-regulated when assembly of the enzyme is blocked.
The failure of cox15 mutants to accumulate heme O in amounts comparable with other cytochrome oxidase mutants (6) suggests that farnesylation of protoheme may also be regulated by a downstream product such as the hydroxylated intermediate or by heme A itself.
